Cardiovascular Systems Inc. (CSII)

44.88
1.00 2.20
NASDAQ : Health Technology
Prev Close 45.89
Open 45.88
Day Low/High 44.76 / 46.52
52 Wk Low/High 24.84 / 45.92
Volume 274.41K
Avg Volume 278.00K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.54B
EPS 0.10
P/E Ratio 735.50
Div & Yield N.A. (N.A)

Latest News

Cardiovascular Systems Reaches Analyst Target Price

Cardiovascular Systems Reaches Analyst Target Price

In recent trading, shares of Cardiovascular Systems, Inc have crossed above the average analyst 12-month target price of $42.67, changing hands for $43.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Cardiovascular Systems, Inc. Announces First Patient Enrolled In REACH PVI Clinical Study

Cardiovascular Systems, Inc. Announces First Patient Enrolled In REACH PVI Clinical Study

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first patient was...

Cardiovascular Systems, Inc. To Present At The Raymond James Life Sciences & MedTech Conference

Cardiovascular Systems, Inc. To Present At The Raymond James Life Sciences & MedTech Conference

On Tuesday, June 18, 2019, Cardiovascular Systems' (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the Raymond James Life Sciences & MedTech Conference at 9:45 a.

Cardiovascular Systems, Inc. Reports Fiscal 2019 Third-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2019 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its...

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 Third-Quarter Earnings Conference Call Wednesday, May 1

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 Third-Quarter Earnings Conference Call Wednesday, May 1

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 third-quarter conference call on Wednesday, May 1, 2019, at 3:30 p.

Cardiovascular Systems, Inc. To Present At Three Upcoming Investor Conferences

Cardiovascular Systems, Inc. To Present At Three Upcoming Investor Conferences

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will...

Washington Real Estate Investment Trust And Cardiovascular Systems Set To Join S&P SmallCap 600

Washington Real Estate Investment Trust And Cardiovascular Systems Set To Join S&P SmallCap 600

NEW YORK, March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Washington Real Estate Investment Trust (NYSE: WRE) will replace Investment Technology Group Inc.

Cardiovascular Systems, Inc. To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Cardiovascular Systems, Inc. To Present At The 8th Annual SVB Leerink Global Healthcare Conference

On Wednesday, February 27, 2019, Cardiovascular Systems' (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8 th Annual SVB Leerink Global Healthcare Conference at 3:00...

Cardiovascular Systems, Inc. Reports Fiscal 2019 Second-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2019 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its...

First Patients In The Middle East Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

First Patients In The Middle East Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in...

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues Of $60.2 Million

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues Of $60.2 Million

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced preliminary and unaudited...

Cardiovascular Systems, Inc. Receives Approval For The Diamondback 360® Coronary Orbital Atherectomy System With Classic Crown And New ViperWire Advance® FlexTip Guidewire In Japan

Cardiovascular Systems, Inc. Receives Approval For The Diamondback 360® Coronary Orbital Atherectomy System With Classic Crown And New ViperWire Advance® FlexTip Guidewire In Japan

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that Japan's Ministry of...

Cardiovascular Systems, Inc. Announces First Patients Treated In United States With OrbusNeich Teleport® Microcatheter

Cardiovascular Systems, Inc. Announces First Patients Treated In United States With OrbusNeich Teleport® Microcatheter

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the first patients in...

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CSII: Insiders Vs. Shorts

CSII: Insiders Vs. Shorts

The most recent short interest data was recently released for the 11/30/2018 settlement date, and Cardiovascular Systems, Inc is one of the most shorted stocks of the Russell 3000, based on 6.58 "days to cover" versus the median component at 5.06. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

First Patients In Europe Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System

First Patients In Europe Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in...

First Patient In Hong Kong Treated With Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

First Patient In Hong Kong Treated With Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in...

Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first...

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 first-quarter conference call on Tuesday, October 30, 2019, at 3:45 p.

Cardiovascular Systems, Inc. Announces First Commercial Launch Of Peripheral Orbital Atherectomy System Outside The United States

Cardiovascular Systems, Inc. Announces First Commercial Launch Of Peripheral Orbital Atherectomy System Outside The United States

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in...

Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes At 2018 Amputation Prevention Symposium

Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes At 2018 Amputation Prevention Symposium

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented two-year outcomes from its...

Cardiovascular Systems, Inc. And Aerolase Corp. Sign Collaborative Agreement For Laser Atherectomy Technology

Cardiovascular Systems, Inc. And Aerolase Corp. Sign Collaborative Agreement For Laser Atherectomy Technology

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that it has signed an...

Cardiovascular Systems, Inc. Reports Fiscal 2018 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal fourth...

Cardiovascular Systems, Inc. Signs International Distribution Agreement With OrbusNeich

Cardiovascular Systems, Inc. Signs International Distribution Agreement With OrbusNeich

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral Orbital Atherectomy Systems (OAS) outside the United States and Japan.

Cardiovascular Systems, Inc. To Release Fiscal 2018 Fourth-Quarter Results On July 30

Cardiovascular Systems, Inc. To Release Fiscal 2018 Fourth-Quarter Results On July 30

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) will release fourth-quarter results on July 30 after market close.

Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third...

Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes At CRT18 Interventional Cardiology Conference

Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes At CRT18 Interventional Cardiology Conference

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease,...

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA Clearance Of The First And Only 1.0mm Coronary Balloon In The U.S.

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA Clearance Of The First And Only 1.0mm Coronary Balloon In The U.S.

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today...

TheStreet Quant Rating: C (Hold)